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ABSTRACT ManyGram-negativebacteriautilizespecializedsecretionsystemstoinjectproteins(effectors)directlyintohostcells.
Littleisknownregardinghowbacteriaensurethatonlysmallsubsetsofthethousandsofproteinstheyencodearerecognizedas
substratesofthesecretionsystems,limitingtheiridentiﬁcationthroughbioinformaticanalyses.Manyoftheseproteinsrequire
chaperonestodirecttheirsecretion.Here,usingthenewlydescribedproteininteractionplatformassay,wedemonstratethat
type3secretionsystemclassIBchaperonesfromonebacteriumdirectlybindtheirowneffectorsaswellasthosefromotherspe-
cies.Inaddition,weobservethatexpressionofclassIBhomologsfromsevenspecies,includingpathogensandendosymbionts,
mediatethetranslocationofeffectorsfrom Shigelladirectlyintohostcells,demonstratingthatclassIBchaperonesareoften
functionallyinterchangeable.Notably,classIBchaperonesbindnumerouseffectors.However,aspreviouslyproposed,theyare
notpromiscuous;rathertheyrecognizeadeﬁnedsequencethatwedesignatetheconservedchaperone-bindingdomain(CCBD)
sequence[(LMIF)1XXX(IV)5XX(IV)8X(N)10].Thissequenceistheﬁrstdeﬁnedaminoacidsequencetobeidentiﬁedforanyin-
terspeciesbacterialsecretionsystem,i.e.,asystemthatdeliversproteinsdirectlyintoeukaryoticcells.Thissequenceprovidesa
newmeanstoidentifysubstratesoftypeIIIsecretionsystems.Indeed,usingapatternsearchalgorithmfortheCCBDsequence,
we have identiﬁed the ﬁrst two probable effectors from an endosymbiont, Sodalis glossinidius.
IMPORTANCE ManyGram-negativepathogensutilizetype3secretionsystemstodelivertensofeffectorsintohostcells.Inorder
tounderstandthediversewaysthattheseorganismscausedisease,itisnecessarytoidentifytheireffectors,manyofwhichre-
quirechaperonestobesecreted.HereweestablishthatclassIBchaperonesarenotpromiscuous,aspreviouslyproposed,but
ratherrecognizeaconservedeffectorsequence.Wedemonstratethatpatternsearchalgorithmsbasedonthisdeﬁnedsequence
canbeusedtoidentifypreviouslyunknowneffectors.Furthermore,weobservethatclassIBchaperonesfromatleastsevenbac-
terialspeciesarefunctionallyinterchangeable.Notonlydotheybindandmediatethedeliveryoftheirownsetofeffectorsinto
hostcellsbuttheyalsobindtotype3substratesfromotherbacteria,suggestingthatinhibitorsthatblockchaperone-effector
interactionscouldprovideanovelmeanstoeffectivelytreatinfectionsduetoGram-negativepathogens,includingorganisms
resistanttocurrentlyavailableantibiotics.
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O
ver30speciesofGram-negativebacteria,bothpathogensand
endosymbionts, utilize type 3 secretion systems (T3SSs) to
deliver tens of proteins, referred to as effectors, directly into host
cells (1). Type 3 effectors target a variety of host cellular processes
to promote bacterial spread and survival. While the protein com-
ponents of these complex secretion machines are highly con-
served,eachbacterialspeciesdeliversitsownuniquerepertoireof
effectors into host cells. Although many effectors require chaper-
onestobesecreted,littleisknownregardinghowtheyaredeﬁned
as type 3 secreted substrates, limiting their identiﬁcation through
bioinformatic analyses.
Extensive work mapping the regions of effectors required for
their secretion has established that two domains play a role, the
N-terminal secretion sequence and, in many cases, a downstream
chaperone-binding domain (2, 3). The N-terminal secretion se-
quenceisnotaspeciﬁcsequence,butrather,asrecentexperimen-
taldatasuggest,anintrinsicallystructurallydisorderedregion(4).
Machine learning algorithms can identify known effectors based
on the nature of their N-terminal residues. However, the full util-
ityofthesealgorithmsinidentifyingneweffectorsisstillunknown
(5–7).
Two distinct but structurally related classes of chaperones me-
diate the secretion of type 3 effectors (8, 9). Class IA chaperones
are almost always located within operons adjacent to the genes
thatencodetheironeortwocognateeffectors.Incontrast,classIB
chaperones are encoded within large operons surrounded by
components of the type 3 secretion machinery rather than effec-
tors. On the basis of the results of structural analyses (10–13), it is
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chaperones via a conserved structural motif, the -strand motif
(11),andthatitislikelythatthechaperone-effectorcomplexisthe
signal recognized by the type III secretion apparatus (10, 11). The
two best-characterized class IB chaperones are Spa15 from Shi-
gellaﬂexneriandInvBfromSalmonellaentericaserovarTyphimu-
rium SPI1 (Salmonella pathogenicity island 1) T3SSs. Each has
been established to mediate the secretion of multiple effectors,
nine in the case of Shigella (14–16) and four in the case of Salmo-
nella (18, 23, 24). Given their ability to interact with numerous
effectors, Spa15 and InvB have been proposed to be promiscuous
in their recognition of effectors (19).
Here, we present evidence that class IB chaperones from seven
different bacterial species, including pathogens and endosymbi-
onts, are functionally interchangeable. Speciﬁcally, class IB chap-
erones from one species can bind and mediate the type 3
secretion-dependent translocation of effectors from another.
TheseclassIBchaperonesarenotpromiscuous,aspreviouslypro-
posed, but rather recognize a deﬁned amino acid sequence motif,
which we designate the conserved chaperone-binding domain
(CCBD). The CCBD overlaps the previously identiﬁed structural
-strand motif, providing evidence that residues of the CCBD
sequence directly bind to chaperones. However, the CCBD dem-
onstrates that class IB chaperones recognize a conserved amino
acid pattern. The CCBD sequence is the ﬁrst identiﬁed deﬁned
amino acid sequence that is common to effectors from any inter-
species bacterial secretion system, i.e., one used by bacteria to
deliver proteins into eukaryotic cells. Uncovering this sequence
not only reﬁnes our understanding of how interactions between
chaperones and effectors are deﬁned but also provides a new
meanstoidentifytype3substratesfrombacteriathatencodeclass
IB. Indeed, based on the results of a pattern search algorithm of
the Sodalis glossinidius genome for proteins that contain the
CCBDsequence,weidentiﬁedtheﬁrsttwolikelyeffectorsfroman
endosymbiont.
RESULTS
Conserved recognition of effectors by Shigella and Salmonella
classIBchaperones.ItiswellestablishedthatclassIAchaperone-
dependent effectors are recognized as substrates of heterologous
T3SSs when their cognate chaperone is also present (20, 21). In
contrast, at the start of this study, little was known regarding the
behavior of class IB chaperone-dependent effectors in heterolo-
goussystems.Forexample,itwasnotknownwhether“promiscu-
ous” chaperones from one system could bind and mediate the
secretionofeffectorsfromanother.Toinvestigatethispossibility,
we tested whether class IB chaperones from Shigella and Salmo-
nella could bind each other’s effectors using the Saccharomyces
cerevisiaeyeast-basedproteininteractionplatform(PIP)assay,an
assay previously established to be more sensitive than the yeast
two-hybrid assay in detecting chaperone-effector interactions
(16).
The PIP assay is a visualization system for identifying interact-
ing proteins in living cells. In this assay, one protein is fused to
NS, a reoviral protein that forms inclusions (platforms) when
expressed in eukaryotic cells; a second protein is fused to a ﬂuo-
rescent protein (16). When coexpressed in yeast, if the two pro-
teins interact, the ﬂuorescent fusion protein is recruited to the
platforms and ﬂuorescent foci are observed. Using the PIP assay,
we observed interactions between Salmonella InvB and 10 of 23
Shigella effectors, the same 10 that interact with Shigella Spa15 in
the PIP assay (see Fig. S1A in the supplemental material) (16). In
all but one case, the majority of yeast cells visualized exhibited
ﬂuorescent foci. The exception was green ﬂuorescent protein
(GFP)-IpgB1, where the percentage of yeast cells that displayed
ﬂuorescentfociwithexpressionofNS-InvBandGFP-IpgB1was
decreased compared to those expressing NS-Spa15 and GFP-
IpgB1 (34 versus 68%). This observation suggests that IpgB1 in-
teracts more weakly with InvB than Spa15, as recent studies dem-
onstrate that the percentage of yeast displaying ﬂuorescent foci
reﬂecttherelativeinvitrobindingafﬁnitiesofthetwoproteinsfor
each other (22).
In a complementary set of PIP assays, Salmonella InvB and
ShigellaSpa15eachinteractedwiththreeSalmonellaeffectorsthat
require InvB for their efﬁcient secretion by the Salmonella T3SS
(SopA, SopE1, and SopE2) (see Fig. S1B in the supplemental ma-
terial) (18, 23, 24). However, the fourth Salmonella InvB-
dependent effector, SipA, bound only InvB. Neither InvB nor
Spa15 interacted with any of the 13 Shigella effectors previously
established to not require Spa15 for their secretion, including
thosethatbindclassIAchaperones,demonstratingthattheseclass
IB chaperones exhibit some speciﬁcity in their interactions
(Fig. S1C) (16).
Complementation of secretion of Shigella Spa15-dependent
effectorsbySalmonellaInvB.Todeterminewhethertheinterac-
tions detected in the PIP assay were physiologically relevant, we
tested whether expression of the Salmonella InvB chaperone
would restore secretion of Shigella Spa15-dependent effectors
from a strain lacking Spa15 (Shigella spa15 mutant). Comple-
mentation with InvB restored secretion to essentially wild-type
levels for eight of the nine Shigella Spa15-dependent effectors
(Fig. 1A), all but IpgB1, the effector that exhibited decreased in-
teraction with InvB in the PIP assay. Similarly, secretion of the
three Salmonella InvB-dependent effectors that bind Spa15
(SopA, SopE1, and SopE2) from the Shigella spa15 mutant was
only observed with complementation by either Spa15 or InvB
(Fig. 1B). SipA, the only Salmonella InvB effector that interacted
exclusively with InvB in the PIP assay, was secreted at relatively
lowlevelsfromboththewild-typeShigellaandtheShigellaspa15
mutant,suggestingthatitcanbesecretedintheabsenceofachap-
erone. Complementation of the Shigella spa15 mutant strain
with Salmonella InvB, but not Shigella Spa15, results in increased
levels of secreted SipA (Fig. 1B). Together, the results of these
studies demonstrate that the class IB chaperones from Salmonella
andShigellaarenearlyfunctionallyinterchangeable.Thesearethe
ﬁrstclassIchaperonesyettobeidentiﬁedtobindandpromotethe
secretion of each other’s effectors.
Fortheseexperiments,epitope-taggedversionsofeacheffector
were expressed under the control of a weakened version of the
isopropyl--d-thiogalactopyranoside (IPTG)-inducible trc pro-
moter from a low-copy-number plasmid (pBR ori) (25). This al-
lowed us to ensure that the effectors were expressed at close to
physiologiclevelswhentype3secretionwasinduced(16),sinceat
least in the case of Shigella OspF, this system results in similar
levelsofexpressionasobservedundernativeconditions(datanot
shown). Similarly, for the complementation experiments, Spa15
andInvBwereexpressedunderthecontrolofaweakenedtrcpro-
moterfromanotherlow-copy-numberplasmid(pSC101ori).We
observed no differences in the levels of secretion of each of the 9
Spa15-dependenteffectorsfromwild-typeShigellaversusShigella
Costa et al.
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suggesting that the phenotypes observed are not due to Spa15 or
InvB overexpression. Thus, Salmonella InvB and Shigella Spa15
are able to recognize and mediate the secretion of a subset of each
other’s effectors.
Identiﬁcation of a conserved CCBD sequence. The observa-
tion that Spa15 and InvB recognize the same subset of effectors
suggested that these chaperones are discriminate in their recogni-
tion of effectors and led us to search for a conserved chaperone-
binding domain (CCBD) sequence. Previous studies had failed to
recognize a sequence common to all type 3 effectors. However,
when we restricted our alignment studies to the N-terminal 70
residues of the 13 Shigella and Salmonella effectors that interact
with Spa15 and/or InvB, we identiﬁed a shared sequence,
(LMIF)1XXX(IV)5XX(IV)8X(N)10 (Fig. 2A). Interestingly, the
onlyeffectorthatdoesnotcontainisoleucineorvalineatposition
5i sSalmonella SipA, the effector that interacts exclusively with
Salmonella InvB. This consensus sequence is not found in any of
the 11 Shigella effectors that do not require Spa15 for their secre-
tion (16) or in any Salmonella effectors,
other than those that interact with InvB.
This sequence is the ﬁrst deﬁned amino
acidsequencethathasbeenidentiﬁedthat
is shared by secreted effectors of any in-
terspecies bacterial secretion system, and
we designate it the conserved chaperone-
binding domain sequence.
Site-directedmutagenesisstudiescon-
ﬁrmed a role for the CCBD sequence in
mediating chaperone-effector interac-
tions. The conversion of all four of the
conserved residues (positions 1, 5, 8, and
10) of the CCBD sequence of Shigella
OspC1 or OspD1 to alanines completely
abolished their secretion via the Shigella
T3SS (Fig. 2B) and resulted in loss of in-
teraction of OspD1 and Spa15 in the PIP
(Fig. 2C) and yeast two-hybrid (Y2H)
protein-protein interaction assays (see
Table S1 in the supplemental material).
We also examined whether single muta-
tionsatposition1,5,8,or10oftheCCBD
sequence would disrupt secretion and/or
chaperone binding. For these studies,
each residue was mutated to glycine to
disrupt the hydrophobic contacts pre-
dicted to mediate chaperone-effector in-
teraction in accordance with the corre-
sponding positions in the SipA-InvB
crystalstructure.Pointmutationsatposi-
tions1and10,thelessconservedresidues,
resulted in a mild-to-moderate decrease
in secretion, while mutation of either po-
sition5or8,positionsinvariantlypresent
as isoleucines or valines, essentially dis-
rupted all secretion (Fig. 2D). In each
case,thesinglepointmutationsdisrupted
interactionsbetweenSpa15andOspD1in
the PIP and Y2H assays (Table S1) with
the magnitude of loss paralleling the ob-
served loss in secretion (Fig. 2C). Since decreased interactions in
the PIP and Y2H assays are both associated with decreased bind-
ing afﬁnities determined in vitro (22, 26), these observations sug-
gest that these residues of the CCBD sequence directly bind class
IB chaperones, as observed in the SipA-InvB cocrystal structure
(11).
InteractionsbetweentheCCBDandclassIBchaperonesde-
termine substrate speciﬁcity. We next investigated whether in-
teractions between the CCBD and class IB chaperones are sufﬁ-
cient to deﬁne chaperone substrate speciﬁcity. To address this
question, we exploited our earlier observations that Salmonella
InvB binds and complements the secretion of all of the Shigella
CCBD-containingeffectorsexceptforIpgB1(Fig.1).IpgB1shares
a high degree of structural homology with IpgB2 (27), another
Shigella CCBD-containing effector, suggesting that the unstruc-
tured N-terminal regions of these proteins dictate whether InvB
recognizes them as effectors. Indeed, by swapping the ﬁrst 47 res-
idues of IpgB1 with the ﬁrst 50 residues of IpgB2 (the respective
regionsoftheeffectorslocatedupstreamoftheirconservedstruc-
FIG 1 Shigella and Salmonella class IB chaperones are functionally interchangeable. S. ﬂexneri strains
(wild type, spa15 mutant, and the spa15 mutant complemented with Shigella Spa15 or Salmonella
InvB) and expressing the designated FLAG-tagged Shigella (A) or Salmonella (B) effectors were grown
underconditionsthatinduceT3SS.ThesupernatantproteinswereprecipitatedwithTCA,separatedby
SDS-PAGE, and immunoblotted with anti-FLAG and anti-IcsA antibodies. IcsA is an autotransporter
and secreted by a mechanism other than type 3 secretion and serves as a loading control. The blots
shown are representative of at least three experiments.
Interchangeable Class IB Chaperones Recognize CCBD
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nowrecognizesIpgB1,butnotIpgB2,asatype3substrate(Fig.3A
and B). This substrate speciﬁcity is not determined by the
N-terminal secretion signal, as additional swaps established that
substrate speciﬁcity maps to regions that encompass the CCBD
sequences of the two proteins (Fig. 3A and B). The switch in rec-
ognition of the IpgB1/IpgB2 hybrids likely represents differences
intheirbindingafﬁnities,astheabilityofInvBtocomplementthe
secretion of these proteins from the Shigella spa15 mutant cor-
relates with its capacity to bind the proteins in the PIP assay
(Fig. 3C). All of the hybrid effectors were secreted by the Shigella
spa15 mutant in the presence of Spa15 (Fig. 3B). These observa-
tions suggest that the CCBD is a major determinant in deﬁning
interactions between effectors and class IB chaperones.
TheCCBDsequenceisuniquetoeffectorsthatbindclassIB
chaperones. Notably, at least in the case of SipA, whose crystal
structure in complex with InvB has been solved, the CCBD do-
main overlaps with the -strand motif, a region characterized by
three hydrophobic residues () separated by 1 to 4 variable resi-
dues (X2–4X1–2) (11). This structural motif is found in effec-
tors that bind class IA and IB chaperones. Unlike the CCBD se-
quence, there is no sequence conservation of residues in the
-strandmotifotherthantheirhydrophobicnature.Over35type
3 effectors have been proposed to contain the structural -strand
motif, including those dependent on Spa15 or InvB for their se-
cretion (11). We randomly selected and tested whether nine of
these effectors (Salmonella SifA, SifB, SigD, SptP, and SseJ, Esche-
richia coli EspH, Map, and Tir, and Yersinia pseudotuberculosis
YopH)interactwithSpa15orInvBinthePIPassay(seeFig.S2Ain
the supplemental material). This set included six effectors (SigD,
SptP, EspH, Map, Tir, and YopH) previously shown to bind class
IA chaperones. None of these effectors interacted with Spa15 or
InvB. Similarly, we observed no interactions in the PIP assay be-
tween the nine Shigella CCBD-containing effectors and two atyp-
FIG 2 Identiﬁcation of the conserved chaperone-binding domain, a sequence common to Shigella and Salmonella class IB-dependent effectors. (A) Multiple-
sequence alignment of effectors whose secretion is promoted by InvB or Spa15. The CCBD sequence is shown in large red letters. (B to D) Wild-type Shigella
expressing epitope-tagged alleles of wild-type (wt) and mutant alleles of OspC1 and OspD1 were grown under conditions that induce T3SS. The residues at
positions 1, 5, 8, and 10 in CCBD* were changed to alanines. The supernatant and pellet fractions were immunoblotted with anti-FLAG antibody to assess for
secretionandproteinstability,respectively.Thesupernatantfractionswerealsoimmunoblottedwithanti-IcsAantibodyasaloadingcontrol.Allblotsshownare
representativeofatleastthreeexperiments.(C)YeastcoexpressingNS-Spa15andthedesignatedGFP-OspD1alleleswerevisualized4to5hoursafterinduction
of each protein in the PIP assay. The percentage of yeast expressing ﬂuorescent foci (pips) was determined by counting 100 cells. The values shown are
representative of two independent experiments done in triplicate.
Costa et al.
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pleeffectors,CesTfromenterohemorrhagicE.coliandSrcAfrom
the Salmonella SPI2 T3SS (Fig. S2C) (28, 29). Therefore, we hy-
pothesize that the amino acid sequence of the CCBD deﬁnes the
speciﬁcityofinteractionsofclassIBchaperoneswiththeircognate
effectors.
Conserved recognition of CCBD-containing effectors by
classIBchaperonesindistantlyrelatedspecies.Wenextinvesti-
gated whether the recognition of CCBD-containing effectors is
restrictedtocloselyrelatedpathogenslikeShigellaandSalmonella
orafeaturecommontoallclassIBchaperones.Towardsthisgoal,
we tested the ability of seven additional class IB chaperones, four
from human pathogens (Proteus mirabilis [30]), Burkholderia do-
losa, Burkholderia mallei [31] and Yersinia enterocolitica [32]) and
threefromendosymbionts(Sodalisglossinidius[33,34]andHam-
iltonella defensa [35]) to bind to Shigella CCBD-containing effec-
tors. Sodalis glossinidius, a tsetse ﬂy endosymbiont, contains three
T3SSs, two of which (SSR1 and SSR2) encode InvB homologs.
Similarly,Y.enterocoliticaencodestwoT3SSs,thewell-studiedYsc
T3SS and the relatively poorly character-
ized Ysa T3SS. Only the latter system en-
codes a class IB chaperone.
To increase the throughput of our
protein interaction studies, we developed
an automated microscopy-based version
of the PIP assay. Automating the PIP as-
say decreased the time needed for image
acquisition and analysis allowing for the
rapid analysis of hundreds of yeast cells
for the formation of ﬂuorescent foci
(pips) (Fig. 4A). One issue we encoun-
tered with the automated PIP assay was
that the segmentation software used had
difﬁculty identifying ﬂuorescent foci in
yeast that express weakly ﬂuorescent GFP
fusion proteins, speciﬁcally GFP-OspB,
GFP-OspC3, and GFP-OspD2. To ac-
count for differences in GFP intensities
(Fig. 4B), for each effector protein, we
normalized the number of yeast that ex-
hibited ﬂuorescent foci with each ho-
molog to those observed with Shigella
Spa15.
As summarized in Fig. 4B (raw data
shown in Fig. S3A in the supplemental
material), all of the class IB chaperones,
except those from the Sodalis SSR1 and
B. mallei T3SSs, interacted with Shigella
CCBD-containing effectors. The lack of
detection of interactions of the Sodalis
SSR1 and B. mallei homologs with effec-
tors was not due to their inability to form
platformsinyeast,asﬂuorescentfociwere
observed when each of these chaperones
was simultaneously fused to a cyan ﬂuo-
rescent protein-NS fusion protein
(Fig. S3B).
Functionally interchangeability as a
general feature of class IB chaperones.
To conﬁrm that the chaperone-effector
interactions detected in the PIP assay were physiologically rele-
vant,weinvestigatedwhethereachoftheclassIBhomologscould
complement translocation of the nine Shigella CCBD-containing
effectors using the well-established TEM-1 -lactamase reporter
assay (36). Brieﬂy, in this assay, HeLa cells are preloaded with
CCF4/AM, a ﬂuorescence resonance energy transfer (FRET)-
based dye, that emits green ﬂuorescence. When translocated into
host cells, the TEM-1 -lactamase fusion proteins cleave the sub-
strate, disrupting FRET and resulting in cells that emit blue ﬂuo-
rescence (Fig. 5A). The translocation efﬁciency of each effector
corresponds to the percentage of cells that ﬂuoresce blue.
To facilitate our studies, we adapted the TEM-1 -lactamase
reporter assay to monitor the translocation of Shigella effectors
into HeLa cells in a 96-well format. Effector–TEM-1 fusions were
expressed under the control a weakened trc IPTG-inducible pro-
moter from a low-copy-number plasmid (pBR ori). After the ex-
pression of effectors was induced, HeLa cells were infected with
Shigellaatamultiplicityofinfection(MOI)of100for2h.Thecells
were examined and the numbers of green and blue cells were
FIG 3 The CCBD sequence deﬁnes chaperone-effector interactions. (A) Schematic of IpgB1/IpgB2
hybrid proteins used in this study. (B) Shigella spa15 mutant complemented with Spa15 or InvB and
expressing epitope-tagged alleles of the designated IpgB1 or IpgB2 hybrid proteins grown under con-
ditions that induce T3SS. The supernatant fractions were immunoblotted with anti-FLAG antibody to
assess for secretion. The supernatant fractions were also immunoblotted with anti-IcsA antibody as a
loading control. (C) Yeast coexpressing NS-Spa15 or NS-InvB and the designated IpgB1/IpgB2
alleleswerevisualized4to5hoursafterinductionofeachproteininthePIPassay.Thepercentofyeast
expressing ﬂuorescent foci (pips) was determined by counting 100 cells. The values shown are repre-
sentative of two independent experiments done in triplicate.
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ourhigh-throughputstudiesgiventhatat
the 2-h time point we observed similar
levels of translocation of all nine effectors
into host cells with wild-type Shigella and
the Shigella spa15 mutant comple-
mented with Spa15 (Fig. S4A in the sup-
plemental material).
As summarized in Fig. 6B and shown
in Fig. S4A in the supplemental material,
alloftheclassIBchaperones,exceptthose
from the Sodalis SSR1 and B. mallei
T3SSs, complemented the translocation
of CCBD-containing effectors from the
Shigella spa15 mutant into host cells.
Lack of translocation by the Sodalis SSR1
and B. mallei chaperones was not due to
lackofexpressionordecreasedstabilityof
these proteins, as both effectors are pres-
ent at levels similar to Spa15 in Shigella
(Fig. S4B). Rather, as neither interact
with CCBD-containing effectors in the
PIP assay, it is likely that these homologs
do not complement secretion because
they do not bind the effectors. Interest-
ingly, Sodalis SSR2, like Salmonella InvB,
poorly complemented the translocation
of IpgB1. Consistent with this observa-
tion, the Sodalis SSR2 homolog, like Sal-
monella InvB, complements the secretion
into the media of all the Shigella CCBD-
containing effectors, except for IpgB1
(Fig. S5). Taken together, the PIP and
translocation assay results suggest that,
with the exception of homologs from the
SodalisSSR1andB.malleiT3SSs,thema-
jorityofclassIBchaperonesarefunction-
ally interchangeable and recognize a con-
served amino acid domain, the CCBD
sequence.
Identiﬁcation of the ﬁrst effectors
from an endosymbiont based on a pat-
tern search algorithm for the CCBD
sequence. While the proteins that com-
prise T3SSs, including class IB chaper-
ones, are highly conserved, each bacterial
species delivers its own unique set of ef-
fectors into host cells. Although class IB
chaperonescanbeidentiﬁedbasedonho-
mology searches, with the exceptions of
Shigella Spa15 and Salmonella InvB, none
of their cognate effectors are known.
Sincemostofthehomologsbindandme-
diate the translocation of Shigella CCBD-
containing effectors, we reasoned that we
could identify their native effectors by
searching their respective genomes for
open reading frames (ORFs) that contain
the CCBD sequence. We focused our ini-
tial studies on Sodalis glossinidius, partic-
FIG 4 Summary of interactions of class IB chaperones with CCBD-containing effectors obtained by
automated microscopy. (A) Images of yeast expressing GFP-OspD1 in the presence of either NS
(negativecontrol)orNS-Spa15(positivecontrol)obtainedviaautomatedmicroscopy.Theimagesin
the left column are unprocessed, while the images in the right column represent pip-positive (green)
andpip-negative(red)yeastasdeterminedbytheINCellWorkstationsegmentationsoftware.(B)The
heatmap shown (45) represents relative number of yeast with ﬂuorescent foci (pips) visualized with
coexpressionofthedesignatedNS-classIBchaperoneandGFP-effectorfusionproteinpairs.Foreach
GFP fusion protein, the absolute percentage of yeast expressing ﬂuorescent foci was normalized to the
absolute percentage of yeast expressing ﬂuorescent foci when the GFP-effector fusion protein was
coexpressed with NS-Spa15. The data are representative of 3 independent experiments done in du-
plicate. At least 6,000 cells were quantiﬁed per condition.
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identiﬁed.UsingtheBioinformaticsToolkitpatternsearchalgorithm
(37) for the CCBD sequence [(LMIF)1XXX(IV)5XX(IV)8X(N)10]i n
the ﬁrst 25 to 45 N-terminal residues of annotated ORFs (a region
chosenbasedonthelocationoftheCCBDsequenceinall13Shigella
and Salmonella Spa15/InvB-dependent effectors), we identiﬁed 13
Sodalis proteins, 9 of which are annotated as housekeeping proteins.
We focused our studies on the remaining proteins that were anno-
tated as hypothetical ORFs (see Fig. S6A in the supplemental mate-
rial).
Two of these four Sodalis glossinidius proteins, SG0576 and
SG0764,werestablyexpressedinShigella,
and both of these were secreted into the
media by wild-type Shigella under condi-
tions that induce type 3 secretion
(Fig. 6A). The secretion of both was im-
paired or absent from the Shigella spa15
mutant, and as predicted based on the re-
sultsofbindingandtranslocationstudies,
expression of the class IB homolog from
the Sodalis SSR2, but not the SSR1 T3SS,
restored secretion of both proteins from
theShigellaspa15mutant(Fig.6A).Nei-
ther protein was secreted from a Shigella
strain that does not form a functional
T3SS due to loss of expression of the
structuralproteinMxiM(ShigellamxiM
mutant)(seeFig.S6Binthesupplemental
material) (38). Last, SG0576 and SG0764
were both translocated into host cells via
the Shigella T3SS in a class IB chaperone-
dependent manner (Fig. 6B). Together,
these observations strongly suggest that
theseproteinsaresubstratesoftheSodalis
SSR2 T3SS. Thus, we have identiﬁed the
ﬁrst type 3 effectors from an endosymbi-
ont.
DISCUSSION
Many Gram-negative bacteria utilize
T3SSs to deliver tens of proteins directly
into host cells during the course of an in-
fection. The identiﬁcation of effectors re-
mains challenging, even in the postgen-
omics era, in part given their lack of a
deﬁned searchable conserved secretion
signal. Here, we demonstrate that class IB
chaperones are not promiscuous, as pre-
viously proposed, but rather recognize a
deﬁned amino acid sequence, which we
designate the conserved chaperone-
binding domain. This CCBD sequence is
recognized by class IB chaperones from
both endosymbionts and animal patho-
gens. Seven of the nine class IB homologs
studied here not only bound CCBD-
containingeffectorsbutwerefunctionally
interchangeable in the context of the Shi-
gella T3SS. Notably, by using a pattern
search algorithm to screen for proteins
that contain the CCBD sequence, we successfully identiﬁed the
ﬁrstputativeeffectorsfromanendosymbiont,Sodalisglossinidius.
Candidate effectors have traditionally been identiﬁed from
bacterial genome sequences by searching for proteins that share
sequence similarity with type 3 effectors or mammalian proteins
as well as by focusing on those encoded by genes within pathoge-
nicityislandsorexhibitadistinctiveGCcontent.Recently,several
groups have developed machine learning algorithms to identify
candidate effectors based on their N-terminal 15 to 20 residues,
the secretion signal. Curiously, using available Web-based tools
for two of these algorithms, we found that the SIEVE (39) and
FIG5 Functional interchangeability of class IB chaperones in a type 3 translocation assay. (A) Images
of HeLa cells preloaded with CCF4/AM infected with wild-type (WT) Shigella or Shigella spa15
mutant expressing OspD1–TEM-1. (B) The heatmap shown (45) is representative of the percent blue
cells observed when the HeLa cells were infected with Shigella spa15 mutant strain that carries plas-
mids that express the designated class IB chaperone with each of the effector–TEM-1 fusion proteins.
Translocation was quantiﬁed by measuring the percentage of cells that ﬂuoresce blue (cleaved CCF4/
AM). Data are representative of two independent experiments done in triplicate and at least 600 cells
were counted for each sample.
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gella,Salmonella,andSodalisCCBD-containingeffectors,suggest-
ing that CCBD-based searches will lead to the identiﬁcation of
effectors missed by the machine learning algorithms.
While the conserved residues of the CCBD are clearly impor-
tant, they are not sufﬁcient to deﬁne effectors, as this sequence is
foundinbacterialhousekeepingproteins,whichareunlikelytobe
secreted. This is not surprising, as additional determinants play a
role in deﬁning effectors. For example, our pattern search algo-
rithmsfortheCCBDsequencemotifdonotselectforproteinsthat
encode an N-terminal secretion signal. In addition, it is possible,
that the variable residues of the CCBD sequence, the residues in-
dicated as X in the consensus sequence, play a role in deﬁning an
effector. Curiously, these residues in the veriﬁed effectors are en-
richedfornucleophilicandchargedresidues.Thisisaparticularly
interesting ﬁnding, as recent work suggests that the three-
dimensional structure of the chaperone-effector complex deﬁnes
the secretion signal (10, 40). Last, binding to the chaperone does
notensurethataproteinissecretedviatheT3SS,aspriortobeing
secreted,theeffectorsareunfoldedbyanT3SS-associatedATPase
that presumably enables them to be transported through a ~20-
angstrom channel into host cells. Indeed, heterologous proteins
with high intrinsic stability that have been engineered to encode
amino-terminalsecretionsignalsarenotsecreted(41).Futureex-
perimental work and bioinformatic analyses designed to address
the possibilities outlined above will likely result in reﬁnements
that improve the speciﬁcity of pattern search algorithms for the
detection of effectors.
Insummary,ourcurrentworkdemonstratesthatbyexploiting
the functional interchangeability of class IB chaperones and their
conserved recognition of the CCBD sequence motif we have de-
veloped a new experimental genome-mining means for the iden-
tiﬁcation of previously unknown effectors. Notably, while it is
relatively straightforward to monitor the secretion and transloca-
tion of Shigella effectors, with the exception of the Salmonella SPI
T3SS,invitroconditionsthatinduceotherT3SSgenesthatencode
class IB chaperones are currently unknown. However, as demon-
strated with Sodalis CCBD-containing effectors, candidate effec-
tors from bacteria that encode functionally interchangeable class
IB chaperones can be screened for those that are recognized as
substrates of the Shigella T3SS. Once likely effectors of these rela-
tivelypoorlycharacterizedT3SSsareidentiﬁed,theseproteinscan
be used as a readout to identify in vitro conditions that induce
their respective native T3SSs. Furthermore, our discovery that
class IB chaperones recognize a conserved sequence provides a
new means to pursue the development of novel antimicrobial
agents using rationale drug design approaches.
MATERIALS AND METHODS
Plasmids. All of the plasmids involving S. ﬂexneri and many of the S. Ty-
phimuriumORFshavebeenpreviouslydescribed(16,42).Theremaining
bacterial and yeast expression plasmids were created via Gateway (Invit-
rogen) site-speciﬁc recombination (16).
Basically, the ORF encoding each effector and each chaperone was
ampliﬁed from genomic DNA (gDNA) by nested PCR such that it is
ﬂanked by attB sites. In addition to an attB site, a Shine-Dalgarno se-
quence was introduced upstream of each ORF. We created open (lacking
astopcodon)andclosedversionsofeachORFwhencarboxyfusionswere
desired. Mutant alleles of the effectors were created by sewing PCR. The
ampliﬁedgeneswerethenintroducedintopDNR223and/orpDNR221to
create Gateway entry vectors via BP reactions (Invitrogen). Each insert
FIG 6 SG0567 and SG0764 are the ﬁrst identiﬁed effectors from an endo-
symbiont. (A) Wild-type Shigella or the Shigella spa15 mutant comple-
mented with the Spa15 homologs from the Sodalis SSR1 or SSR2 T3SSs and
expressing FLAG-tagged Sodalis candidate effectors were grown under condi-
tions that induce T3SS. The supernatant proteins were immunoblotted with
anti-FLAG and anti-IcsA antibodies. The blots shown are representative of at
leastthreeexperiments.(B)HeLacellspreloadedwithCCF4/AMwereinfected
with wild-type Shigella or the Shigella spa15 mutant expressing the desig-
nated protein fused to TEM-1 for 2 hours. The cells were ﬁxed, and the per-
centage of blue cells were determined. Values are representative of three inde-
pendentexperimentsdoneintriplicate,andatleast600cellswerecountedfor
each sample (means plus standard errors of the means [SEM] [error bars] are
shown).
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way destination vectors via LR reactions (Invitrogen).
For the NS fusion proteins in the PIP assays, the chaperones and
effectors were introduced into pAG416GAL-NS-ccdB, pAG415GAL-
NS-ccdB, and/or pAG415GAL-CFP-NS-ccdB. For the GFP fusion
proteins, the chaperones and the Salmonella effectors, with the exception
of SipA, were introduced into pAG413GAL-GFP-ccdB and pBY011 (43).
Conventional cloning was used created GFP-SipA (amino acids 1 to 254)
in pRS313.
To generate FLAG tag fusions for the secretion assays, the wild-type,
mutant, and hybrid effectors were introduced into pDSW206-FLAG-
ccdB (ColE1 ori, ampicillin resistance) (16, 25), and the chaperones were
introduced into pNG162-ccdB (p204 promoter [IPTG-inducible],
pSC101 ori, spectinomycin resistance) (16, 44).
To generate TEM-1 fusions for the translocation assay, the Shigella
and Sodalis effectors were introduced into pDSW206-TEM-1-ccdB
(ColE1 ori, ampicillin resistance) (a gift from John Leong and Loranne
Magoun, University of Massachusetts Medical School)
Finally, for chaperone stability, chaperones were tagged with Myc at
their N termini and introduced onto the pNG162-ccdB plasmid.
All oligonucleotide primers used in the constructs described here are
described in Table S2 in the supplemental material.
Conventional (manual) PIP assays. Yeast assays were preformed as
previously described (16). Yeast cells were visualized 4 to 6 h after galac-
tose induction using a Nikon TE300 microscope with Chroma Technol-
ogy ﬁlters and a 100 objective. Images were captured digitally using a
black-and-white Sensys charge-coupled-device (CCD) camera and IP
LAB software (Scanalytics).
High-contentimageanalysis(automatedPIPassays).Theyeastcells
were grown in 96-well microtiter plates (Nunc) as previously described
(16)andtransferredinto96-wellmicrotiterplates(BD).Eachexperimen-
talconditionwasperformedinduplicateonaplate.Threesetsofidentical
plates were examined, bringing the total number of replicates to six per
condition. The cells were imaged at a magniﬁcation of 40 in each well
using the IN Cell Analyzer 1000 (GE Healthcare, Piscataway, NJ). Brieﬂy,
the IN Cell Analyzer 1000 is an epiﬂuorescence microscope with fully
automated image acquisition capabilities, including a motorized stage,
motorized ﬁlter wheel, and computer-controlled CCD camera. Three
ﬁelds were preselected to avoid sampling bias throughout the plate. Ex-
posure parameters were empirically optimized for GFP ﬂuorescence to
ensure that images fall within the linear range of exposure. Following
exposure optimization, images were collected in selected wells and stored
for analysis. Images were analyzed using IN Cell Workstation Software
(GE Healthcare). Cells were segmented using the nucleus “Top Hat” al-
gorithm and a 1-m cell collar. Cell detection was determined by endog-
enous GFP expression within the yeast. Foci or pip were identiﬁed as an
organellebetween0.2mand2.0mwithameanorganelleintensity/cell
intensity ratio above 1.5. Output parameters included the following: cell
count, nucleus area (whole yeast cell), nucleus intensity (whole yeast cell
intensity),organellecount,organelleintensity,organelleintensity/cellin-
tensity, percent pip formation, and total number of pip formation. Cells
were classiﬁed as pip positive if cells expressed 1 organelle; otherwise,
cells were classiﬁed as pip negative. Cells not expressing GFP were not
analyzed.
Secretionandchaperonestabilityassays.ThepDSW206-basedplas-
mids encoding each of the IPTG-inducible FLAG-tagged effectors were
transformed into the designated Shigella strains. Complementation ex-
periments were performed with a Shigella spa15 mutant strain, where
homologous chaperones were expressed under an IPTG-inducible
pNG162 vector. Congo red type 3 secretion assays were conducted as
previously described. Basically, the total cell and supernatant fractions
were separated by two centrifugations (each centrifugation at 20,000  g
for 2 min). The cell pellet of the ﬁrst centrifugation was taken as the total
cellfraction.Proteinsinthesupernatantofthesecondcentrifugationwere
precipitated with trichloroacetic acid (TCA) (10% [vol/vol]). Protein
content of the pellet and supernatant fraction were assessed by Western
blotting with anti-FLAG antibody (Sigma). For loading control, mem-
braneswereprobedwithanti-IcsA(anautotransporterthatiscleavedand
released into the media once it reaches the surface of Shigella). We have
previously established that lysis is not an issue using this protocol, as we
rarely,ifever,detectevidenceofcytoplasmicproteins(16)orunprocessed
IcsA.
High-throughput TEM-1-based translocation assay. Translocation
of effectors into HeLa cells was performed as previously described (36)
with minor modiﬁcations. Basically, bacteria were grown overnight in
tryptic soy broth medium (BD Scientiﬁc) in a 96-well plate. In the morn-
ing, the cultures were back diluted (1/100), and 1.0 mM IPTG was added
when the bacterial cultures reached an optical density at 600 nm (OD600)
of 0.6. Thirty minutes after induction, bacteria were centrifuged, and the
pellet was resuspended in phosphate-buffered saline (PBS). HeLa cells
(1.5  104 cells/well, in 96-well black plates with clear bottom [Costar])
preloaded with CCF4/AM according to the manufacturer’s instructions
(Invitrogen) were infected at an MOI of 100. The plates were centrifuged
for 10 min to promote contact of the bacteria with HeLa cells. IPTG
(0.1mM)wasaddedtothemedium,andtheplateswereincubatedat37°C
for2h.Subsequently,theinfectedcellswereﬁxedwithparaformaldehyde,
and the percentage of effector translocated was assessed via ﬂuorescence
microscopy (Nikon TE300 microscope with Chroma Technology ﬁlters
anda40objective)bydeterminingthepercentageofcellsthatﬂuoresce
blue.
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